Chairman Ophthalmology Sector Group Eucomed and Head Market Access EURMEA Alcon
Miguel Bernabeu joined Novartis group (then Sandoz) in 1987 as sales representative. In 1989 he became marketing manager immunology for Spain. From 1992 to 1998 Mr Bernabeu was Head of Global Marketing Immunology during which time he also becale Project Manager Development for a new immunosuppressant and President of a biotech company. From 98 to 2000 head marketing and sales Novartis Turkey.
Following positions as country head for Argentina, Uruguay and Chile; COO Italy and Head of Market Access Europe, Mr Bernabeu is since 2011 the Head of Market Access EURMEA in Alcon.
1 blog from the author
Raising patients’ awareness on treatment options for cataract
The rapid ageing of the European population has urged the need for prevention and proper treatment of age-related diseases. Amongst these priorities and priority diseases, Cataract is today the major cause of vision impairment of senior citizens worldwide, responsible of 48 % of blindness around the globe.